Olivier Patey
Saint-georges-sur-moulon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Abdominal Tuberculosis: Experience from Two Tertiary-Care Hospitals in the Paris Region.
Journal: The American journal of tropical medicine and hygiene
Published: November 18, 2020
Unconventional diagnostic tests for Lyme borreliosis: a systematic review.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 11, 2019
Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review with a Focus on Osteoarticular Infections.
Journal: Viruses
Published: November 27, 2018
Re-emergence of Corynebacterium diphtheriae.
Journal: Medecine et maladies infectieuses
Published: October 30, 2017
A bacteriophage journey at the European Medicines Agency.
Journal: FEMS microbiology letters
Published: November 25, 2015
Molecular epidemiology and mechanisms of resistance of azithromycin-resistant Neisseria gonorrhoeae isolated in France during 2013-14.
Journal: The Journal of antimicrobial chemotherapy
Published: November 17, 2015
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
Journal: The Journal of antimicrobial chemotherapy
Published: August 06, 2015
Quality and safety requirements for sustainable phage therapy products.
Journal: Pharmaceutical research
Published: December 02, 2014
Toxigenic Corynebacterium ulcerans in a fatal human case and her feline contacts, France, March 2014.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: October 14, 2014
Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.
Journal: AIDS (London, England)
Published: May 29, 2014
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
Journal: The Lancet. Infectious diseases
Published: April 15, 2014
Last Updated: 09/26/2026